Barclays Maintains an 'Equalweight' on Calumet Specialty Products Partners (CLMT); Solid Specialty Margins Likely to Persist
Tweet Send to a Friend
Barclays maintains an 'Equalweight' on Calumet Specialty Products Partners (NASDAQ: CLMT), PT $22.
Barclays analyst says, "Specialty margins/volumes continue to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "Specialty margins/volumes continue to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
